Meningococcic infection by Neisseria meningitidis serogroup C;Infeccion meningococica por Neisseria meningitidis serogrupo C

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 15, Issue 7, 1997, Pages 369-372

  Ursua, M Isabel ^a   Rodríguez Mayo, María ^a   Fernández Quintairos, Josefa ^a   Domínguez, Domingo ^a   Luaces, José ^b   Agulla, Andrés ^a  

^a Servicio Cardiología   (Spain)

^b Universidad de La Coruña   (Spain)

Author keywords

Neisseria meningitidis serogroup C; Penicillin resistence

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; PENICILLIN DERIVATIVE; RIFAMPICIN;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; BACTERIAL MENINGITIS; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; FEMALE; HUMAN; MALE; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; PENICILLIN RESISTANCE; SEPSIS; SEX RATIO; SPAIN; CEREBROSPINAL FLUID; CLASSIFICATION; DRUG EFFECT; INFANT; MICROBIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PENICILLIN RESISTANCE; SPAIN;

EID: 0030729542     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lee H, Harrison MD. The worldwide prevention of meningococcal infection. JAMA 1995; 273: 419-421.
2. Berrón S, Vázquez JA. Increase in moderate penicillin resistance and sero-group C in meningococcal strains isolated in Spain. Is there any relationship? Clin Infect Dis 1994; 18: 161-165.
3. Sáez-Nieto JA, Luján R, Berrón S, Campos J, Viñas M, Fusté C et al. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5 year history (1985-1989). Clin Infect Dis 1992; 14: 394-402.
4. Campos J, Trujillo G, Seuba T, Rodríguez A. Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and ampicillin. Antimicrob Agents Chemother 1992; 36: 1.028-1.031.
5. Bermüdez de la Vega JA, Gómez A, Sobrino M, García A, Romero J, González J. Enfermedad meningocócica aguda. Valoración pronóstica. An Esp Pediatr 1993; 39: 214-218.
6. Riordan FA, Marzouk O, Thompson AP, Silk JA, Hart CA. The changing presentations of meningococcal disease. Eur J Pediatr 1995; 154: 472-474.
7. Loscertales M, Ruiz A, Ibarra I, Del Castillo G, Gómez J, Hellado C et al. La sepsis meningocócica en nuestro medio. Estudio de los factures de gravedad del proceso y de la actitud terapéutica durante 10 años. An Esp Pediatr 1991; 34: 349-354.
8. Palmer SR, Corson J, Hall R, Payne S, Ludlow J, Deere B et al. Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect 1992; 25: 321-328.
9. Sholten RJ, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiol Infect 1994; 112: 115-124.
10. Kriz B, Kuzemenska P, Svandova E. Changes in the age distribution of meningitidis diseases in Czechoslovakia. Cesk Epidemiol Mikrobiol Immunol 1989; 38: 213-220.
11. Roca J, Campos J, Monsó G, Trujillo G, Riverola A, Suris JC et al. Meningitis en pediatría. Estudio clínico y epidemiológico de 173 casos. Enf Infec y Microbiol Clin 1992; 10: 79-88.
12. Rathore MH, Rathore S, Easley MA, Ayoub EM. Latex particle agglutination test on the cerebrospinal fluid. A reappraisal. J Fla Med Assoc 1995; 81: 21-23.
13. Coll MT, Uriz MS, Pineda V, Fontanals D, Bella F, Nava JM et al. Meningococcal meningitis with «normal» cerebrospinal fluid. J Infect 1994; 29: 289-294.
14. Jones DM, Sutcliffe EM. Meningococci with reduced susceptibility to penicillin. Lancet 1990; 335: 863-864.
15. Jackson LA, Tenover FC, Baker C, Pikaytis B, Reeves M, Stocker S et al. Prevalence of Neisseria meningitidis relatively resistant to penicillin in United States, 1991. J Infect Dis 1994; 1.969: 438-441.
16. Riley G, Brown S, Krishnan C. Penicillin resistance in Neisseria meningitidis. N Engl J Med 1991; 324: 997.
17. Brunen A, Peetermans W, Verhaegen J, Robberecht W. Meningitidis due to Neisseria meningitidis with intermediate susceptibility to penicillin. Eur J Clin Microbiol Infect Dis 1993; 12: 969-970.
18. Fontanals D, Pineda V, Pons I, Rojo JC. Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain. Eur J Clin Microbiol Infect Dis 1989; 8: 90-91.
19. Campos J. Profilaxis de la infección meningocócica. Enf Infec Microbiol Clin 1990; 8: 193-195.
20. Stroffolini T, Carbonari P. Meningococcal disease in Italy in 1989. Eur J Epidemiol 1992; 8: 114-116.
21. Blondeau JM, Yaschukl Y. In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis. Antimicrob Agents Chemother 1995; 39: 2.577-2.579.
22. Abadi FJ, Yakubu DE, Pennington TH. Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci. J Antimicrob Chemother 1995; 35: 687-690.
23. Pérez-Trallero E, Aldamiz L, Pérez E. Meningococci with increased resistance to penicillin. Lancet 1990; 335: 1.096.